Our Leadership Team
Our founders are globally acknowledged scientists and drug development leaders whose vision is to make a difference in AML patient care.
Leadership Team
Florent Gros
Chief Executive Officer and Founder
Stephan Oehen
Chief Operating Officer and Founder
Philippe Lievre
Chief Business Officer and Founder
Brice Suire
Chief Financial Officer and Founder
Elisabeth Kueenburg
Chief Medical Officer
Department Heads
Malika Souquières
Head Clinical Sciences & Operations
Karen Von Graevenitz
Head Regulatory Affairs
Frédéric David
Head Technical Development
Dymphy Huntjens
Head Clinical Pharmacology
Board of Directors
Our supervisory board is composed of venture capital leaders from leading international venture funds, also joined by Dr. Dhaval Patel, leader in S1P receptor drug developments (Gilenya®).
Manus Rogan
Chair
Dhaval Patel
Director
Marten Steen
Director
Henry Skinner
Director
Lionel Carnot
Director